IP Library › Assignment 044803/0870
Patent Assignment
Reel/Frame 044803/0870

Change of Name

Recorded: 2017-12-08 Pages: 12
Assignor
BIOGEN, INC.
Executed: 2003-11-13
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (3)
Methods of Screening for a Compound That Inhibits the Interaction Between Baff and Bcma
Patent: 8,828,669 →
Application: 13/401,610 →
Publication: US 2012/0214687
Methods of Treating Autoimmune Diseases Using a B-Cell Maturation Antigen (Bcma)
Patent: 9,650,430 →
Application: 14/452,870 →
Publication: US 2015/0139992
Methods of Modulating Immune Responses Using Bcma Polypeptide
Application: 15/595,733 →
Publication: US 2018/0273605
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Assignment of Assignor's Interest Dec 8, 2017
From: TSCHOPP, JURG; SCHNEIDER, PASCAL
To: APOXIS, SA
Reel/Frame 044341/0207 →
Change of Name Dec 8, 2017
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 044796/0054 →
Merger and Change of Name Dec 8, 2017
From: APOXIS SA; TOPOTARGET SWITZERLAND SA
To: TOPOTARGET SWITZERLAND SA
Reel/Frame 044796/0260 →
Assignment of Assignor's Interest Dec 8, 2017
From: THOMPSON, JEFFREY; AMBROSE, CHRISTINE; BROWNING, JEFFREY; MACKAY, FABIENNE
To: BIOGEN, INC.
Reel/Frame 044797/0673 →